These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 24304232)
1. Myocardial ischemia/reperfusion injury: potential of TRPV1 agonists as cardioprotective agents. Vemula P; Gautam B; Abela GS; Wang DH Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):71-8. PubMed ID: 24304232 [TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors. Zhong B; Wang DH Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of DRG-TRPV1 upregulation in myocardial ischemia contributes to exogenous cardioprotection. Xu S; Xu Y; Cheng X; Huang C; Pan Y; Jin S; Xiong W; Zhang L; He S; Zhang Y J Mol Cell Cardiol; 2020 Jan; 138():175-184. PubMed ID: 31836538 [TBL] [Abstract][Full Text] [Related]
4. Exploring the putative role of TRPV Randhawa PK; Jaggi AS Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28599085 [TBL] [Abstract][Full Text] [Related]
5. Activation of transient receptor potential vanilloid 1 protects the heart against apoptosis in ischemia/reperfusion injury through upregulating the PI3K/Akt signaling pathway. Jiang XX; Liu GY; Lei H; Li ZL; Feng QP; Huang W Int J Mol Med; 2018 Mar; 41(3):1724-1730. PubMed ID: 29286076 [TBL] [Abstract][Full Text] [Related]
6. TRPV1 activation exacerbates hypoxia/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction. Sun Z; Han J; Zhao W; Zhang Y; Wang S; Ye L; Liu T; Zheng L Int J Mol Sci; 2014 Oct; 15(10):18362-80. PubMed ID: 25314299 [TBL] [Abstract][Full Text] [Related]
7. Investigating the involvement of TRPV Randhawa PK; Jaggi AS Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):117-126. PubMed ID: 27752734 [TBL] [Abstract][Full Text] [Related]
8. Gadolinium and ruthenium red attenuate remote hind limb preconditioning-induced cardioprotection: possible role of TRP and especially TRPV channels. Randhawa PK; Jaggi AS Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):887-96. PubMed ID: 27118661 [TBL] [Abstract][Full Text] [Related]
9. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats. Singh A; Randhawa PK; Bali A; Singh N; Jaggi AS Cardiovasc Drugs Ther; 2017 Apr; 31(2):133-143. PubMed ID: 28194544 [TBL] [Abstract][Full Text] [Related]
10. A Review on Potential Involvement of TRPV Randhawa PK; Jaggi AS J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):38-45. PubMed ID: 28466657 [TBL] [Abstract][Full Text] [Related]
11. Spinal NGF induces anti-intrathecal opioid-initiated cardioprotective effect via regulation of TRPV1 expression. Cheng XY; Chen C; He SF; Huang CX; Zhang L; Chen ZW; Zhang Y Eur J Pharmacol; 2019 Feb; 844():145-155. PubMed ID: 30529472 [TBL] [Abstract][Full Text] [Related]
12. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection. Randhawa PK; Jaggi AS Eur J Pharmacol; 2015 Jan; 746():180-5. PubMed ID: 25449039 [TBL] [Abstract][Full Text] [Related]
13. Intrathecal lentivirus-mediated RNA interference targeting nerve growth factor attenuates myocardial ischaemia-reperfusion injury in rat. Dou M; Ma Z; Cheng X; Zou G; Xu Y; Huang C; Xiong W; He S; Zhang Y Br J Anaesth; 2019 Oct; 123(4):439-449. PubMed ID: 31383364 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P. Ren JY; Song JX; Lu MY; Chen H Regul Pept; 2011 Aug; 169(1-3):49-57. PubMed ID: 21554904 [TBL] [Abstract][Full Text] [Related]
15. TRPV1 activation is involved in the cardioprotection of remote limb ischemic postconditioning in ischemia-reperfusion injury rats. Gao Y; Song J; Chen H; Cao C; Lee C Biochem Biophys Res Commun; 2015 Aug; 463(4):1034-9. PubMed ID: 26079883 [TBL] [Abstract][Full Text] [Related]
16. 12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1. Sexton A; McDonald M; Cayla C; Thiemermann C; Ahluwalia A FASEB J; 2007 Sep; 21(11):2695-703. PubMed ID: 17470568 [TBL] [Abstract][Full Text] [Related]
17. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933 [TBL] [Abstract][Full Text] [Related]
18. Morphine timing-dependent modulation of TRPV1 phosphorylation correlates with differential morphine effects on myocardial ischemia/reperfusion injury. Wang XM; Li XX; Jiang B; Wang TQ; Guo Z Eur J Pharmacol; 2024 Jul; 975():176648. PubMed ID: 38759706 [TBL] [Abstract][Full Text] [Related]
19. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury. Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506 [TBL] [Abstract][Full Text] [Related]
20. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]